Institutional investors purchased a net $588.1 thousand shares of OHRP during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 18.26% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UNITED CAPITAL FINANCIAL ADVISER... Bought 86.4 Thousand shares of OHR Pharmaceutical Inc
GSA CAPITAL PARTNERS LLP Bought 52.7 Thousand shares of OHR Pharmaceutical Inc